Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
Abstract Background Emerging evidence suggests a potential relationship between gut microbiota and the host response to chemotherapeutic drugs including 5-fluorouracil (5-Fu). Fusobacterium nucleatum (Fn) has been linked to the initiation and progression of colorectal cancer (CRC). Unfortunately, li...
Main Authors: | Sheng Zhang, Yongzhi Yang, Wenhao Weng, Bomin Guo, Guoxiang Cai, Yanlei Ma, Sanjun Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0985-y |
Similar Items
-
Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality
by: Shuang Wang, et al.
Published: (2021-08-01) -
Progress in Fusobacterium nucleatum
by: MAO Xuhu, et al.
Published: (2019-10-01) -
Fusobacterium Nucleatum Empyema: An Atypical Presentation
by: Lucía Barrera López, et al.
Published: (2020-04-01) -
Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
by: Seul A. Lee, et al.
Published: (2019-07-01) -
Investigating a role for Fusobacterium nucleatum in Inflammatory Bowel Disease
by: Strauss, Jaclyn
Published: (2011)